BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers

Most tumours associated with germline BRCA1/BRCA2 loss of function mutations respond to DNA damaging agents, however, some do not. Herein, the authors identify that a subset of breast/ovarian tumors retain a normal allele, which is associated with decreased overall survival after DNA damage-inducing...

Full description

Bibliographic Details
Main Authors:	Kara N. Maxwell, Bradley Wubbenhorst, Brandon M. Wenz, Daniel De Sloover, John Pluta, Lyndsey Emery, Amanda Barrett, Adam A. Kraya, Ioannis N. Anastopoulos, Shun Yu, Yuchao Jiang, Hao Chen, Nancy R. Zhang, Nicole Hackman, Kurt D’Andrea, Robert Daber, Jennifer J. D. Morrissette, Nandita Mitra, Michael Feldman, Susan M. Domchek, Katherine L. Nathanson
Format:	Article
Language:	English
Published:	Nature Portfolio 2017-08-01
Series:	Nature Communications
Online Access:	https://doi.org/10.1038/s41467-017-00388-9

Similar Items

LOSS OF HETEROZYGOSITY IN THE BRCA1 AND BRCA2 LOCUS IN BREAST CANCER
by: M. M. Tsyganov, et al.
Published: (2020-07-01)

Prostate Cancer: Germline Mutations in BRCA1 and BRCA2
by: Pankaja Umarane, et al.
Published: (2023-03-01)

The occurrence of germline <it>BRCA1 </it>and <it>BRCA2 </it>sequence alterations in Slovenian population
by: Hočevar Marko, et al.
Published: (2011-01-01)

Value of the loss of heterozygosity to BRCA1 variant classification
by: Elizabeth Santana dos Santos, et al.
Published: (2022-01-01)

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2.
by: Melissa S Cline, et al.
Published: (2018-12-01)

BRCA1 and BRCA2 germline mutations in Chinese Hakka breast cancer patients
by: Yinmei Zhang, et al.
Published: (2024-01-01)

Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru
by: Yomali Ferreyra, et al.
Published: (2023-08-01)

Germline BRCA1 and BRCA2 mutations and the risk of bladder or kidney cancer in Poland
by: Elżbieta Złowocka-Perłowska, et al.
Published: (2022-04-01)

Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers
by: Jennifer B. Shah, et al.
Published: (2022-11-01)

Prevalence of BRCA1 and BRCA2 germline variants in an unselected pancreatic cancer patient cohort in Pakistan
by: Noor Muhammad, et al.
Published: (2023-11-01)

Is Breast Conserving Surgery Efficacious in Breast Cancer Patients with BRCA1 or BRCA2 Germline Mutation?
by: Emiroglu S, et al.
Published: (2023-02-01)

Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients
by: Yunuo Zhang, et al.
Published: (2022-08-01)

Frequency of germline mutations in BRCA1 and BRCA2 in ovarian cancer patients and their effect on treatment outcome
by: Ashour M, et al.
Published: (2019-07-01)

Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan
by: Hikmat Abdel-Razeq, et al.
Published: (2018-02-01)

An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers
by: Ewa Przybytkowski, et al.
Published: (2020-03-01)

Mechanisms of increased risk of tumorigenesis in <it>Atm </it>and <it>Brca1 </it>double heterozygosity
by: Wang Jufang, et al.
Published: (2011-08-01)

A role of <it>BRCA1 </it>and <it>BRCA2 </it>germline mutations in breast cancer susceptibility within Sardinian population
by: Lovicu Mario, et al.
Published: (2009-07-01)

Prevalence and predictors of germline BRCA1 and BRCA2 mutations among young patients with breast cancer in Jordan
by: Hikmat Abdel-Razeq, et al.
Published: (2021-07-01)

A Case of Triple-Negative Breast Cancer with Germline Pathogenic Variants in Both BRCA1 and BRCA2
by: Miyuki Kitahara, et al.
Published: (2021-11-01)

BRCA Germline Mutations in Prostate Cancer: The Future Is Tailored
by: Felice Crocetto, et al.
Published: (2021-05-01)

Germline mutations in BRCA1 and BRCA2 among Brazilian women with ovarian cancer treated in the Public Health System
by: Caroline de Oliveira Ferreira, et al.
Published: (2024-04-01)

Limited Independent Follow-Up with Germline Testing of Variants Detected in BRCA1 and BRCA2 by Tumor-Only Sequencing
by: Carol J. Nowlen, et al.
Published: (2024-02-01)

A multi-center study to evaluate the impact of germline BRCA1 and BRCA2 mutations on ovarian cancer survival
by: Bolton KL, et al.
Published: (2012-04-01)

Evaluation of germline BRCA1 and BRCA2 mutations in a multi-ethnic Asian cohort of ovarian cancer patients
by: Hasmad, HN, et al.
Published: (2015)

The Features of BRCA1 and BRCA2 Germline Mutations in Hakka Ovarian Cancer Patients: BRCA1 C.536 A>T Maybe a Founder Mutation in This Population
by: Luo Y, et al.
Published: (2022-03-01)

Molecular Trajectory of BRCA1 and BRCA2 Mutations
by: Yuichiro Hatano, et al.
Published: (2020-03-01)

Epistatic relationships in the BRCA1-BRCA2 pathway.
by: Ralph Scully
Published: (2011-07-01)

Double Heterozygosity for Rare Deleterious Variants in the <i>BRCA1</i> and <i>BRCA2</i> Genes in a Hungarian Patient with Breast Cancer
by: László Madar, et al.
Published: (2023-10-01)

BRCA1, BRCA2, and TP53 germline and somatic variants and clinicopathological characteristics of Brazilian patients with epithelial ovarian cancer
by: Caroline Stahnke Richau, et al.
Published: (2024-02-01)

Next-generation sequencing of BRCA1 and BRCA2 genes for rapid detection of germline mutations in hereditary breast/ovarian cancer
by: Arianna Nicolussi, et al.
Published: (2019-04-01)

Reliability of Tumor Testing Compared to Germline Testing for Detecting BRCA1 and BRCA2 Mutations in Patients with Epithelial Ovarian Cancer
by: Christine Bekos, et al.
Published: (2021-06-01)

Controversies and Open Questions in Management of Cancer-Free Carriers of Germline Pathogenic Variants in <i>BRCA1/BRCA2</i>
by: Rinat Bernstein-Molho, et al.
Published: (2022-09-01)

COVID-19 vaccination uptake and safety profile among germline BRCA1 and BRCA2 pathogenic variant carriers in Singapore
by: Zewen Zhang, et al.
Published: (2023-04-01)

Patterns and Prevalence of BRCA1 and BRCA2 Germline Mutations Among Patients with Triple-Negative Breast Cancer: Regional Perspectives
by: Abdel-Razeq H, et al.
Published: (2021-06-01)

Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologies
by: Yonina R. Murciano-Goroff, et al.
Published: (2022-11-01)

COVID-19 vaccination uptake and safety profile among germline BRCA1 and BRCA2 pathogenic variant carriers in Singapore
by: Zhang, Zewen, et al.
Published: (2023)

Association of Cytokeratin 5 and Claudin 3 expression with BRCA1 and BRCA2 germline mutations in women with early breast cancer
by: Sabine Danzinger, et al.
Published: (2019-07-01)

Tumor Testing for Somatic and Germline BRCA1/BRCA2 Variants in Ovarian Cancer Patients in the Context of Strong Founder Effects
by: Ana Peixoto, et al.
Published: (2020-07-01)

BRCA1 and BRCA2 germline mutations in Malaysian women with early-onset breast cancer without a family history.
by: Gaik Theng Toh, et al.
Published: (2008-04-01)

miRNA expression profiling of hereditary breast tumors from BRCA1- and BRCA2-germline mutation carriers in Brazil
by: Danielle Pessôa-Pereira, et al.
Published: (2020-02-01)